ID   KPCG_RAT                Reviewed;         697 AA.
AC   P63319; P05697; Q5FWS3;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   02-OCT-2024, entry version 173.
DE   RecName: Full=Protein kinase C gamma type;
DE            Short=PKC-gamma;
DE            EC=2.7.11.13 {ECO:0000250|UniProtKB:P05129};
GN   Name=Prkcg; Synonyms=Pkcc, Pkcg, Prkcc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=3387228; DOI=10.1093/nar/16.11.5199;
RA   Ono Y., Fujii T., Igarashi K., Kikkawa U., Ogita K., Nishizuka Y.;
RT   "Nucleotide sequences of cDNAs for alpha and gamma subspecies of rat brain
RT   protein kinase C.";
RL   Nucleic Acids Res. 16:5199-5200(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3755379; DOI=10.1016/0092-8674(86)90874-3;
RA   Knopf J.L., Lee M.-H., Sultzman L.A., Kriz R.W., Loomis C.R., Hewick R.M.,
RA   Bell R.M.;
RT   "Cloning and expression of multiple protein kinase C cDNAs.";
RL   Cell 46:491-502(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-56.
RX   PubMed=2246272; DOI=10.1016/s0021-9258(17)45468-8;
RA   Chen K.H., Widen S.G., Wilson S.H., Huang K.P.;
RT   "Characterization of the 5'-flanking region of the rat protein kinase C
RT   gamma gene.";
RL   J. Biol. Chem. 265:19961-19965(1990).
RN   [5]
RP   FUNCTION.
RX   PubMed=9287082;
RX   DOI=10.1002/(sici)1098-1063(1997)7:4<427::aid-hipo8>3.0.co;2-f;
RA   Krugers H.J., Douma B.R., Andringa G., Bohus B., Korf J., Luiten P.G.;
RT   "Exposure to chronic psychosocial stress and corticosterone in the rat:
RT   effects on spatial discrimination learning and hippocampal protein kinase
RT   Cgamma immunoreactivity.";
RL   Hippocampus 7:427-436(1997).
RN   [6]
RP   FUNCTION IN INFLAMMATORY PAIN, AND SUBCELLULAR LOCATION.
RX   PubMed=10336135; DOI=10.1016/s0306-4522(98)00314-5;
RA   Martin W.J., Liu H., Wang H., Malmberg A.B., Basbaum A.I.;
RT   "Inflammation-induced up-regulation of protein kinase Cgamma
RT   immunoreactivity in rat spinal cord correlates with enhanced nociceptive
RT   processing.";
RL   Neuroscience 88:1267-1274(1999).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF GRIA4/GLUR4, INTERACTION WITH GRIA4/GLUR4,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=12471040; DOI=10.1074/jbc.m205587200;
RA   Correia S.S., Duarte C.B., Faro C.J., Pires E.V., Carvalho A.L.;
RT   "Protein kinase C gamma associates directly with the GluR4 alpha-amino-3-
RT   hydroxy-5-methyl-4-isoxazole propionate receptor subunit. Effect on
RT   receptor phosphorylation.";
RL   J. Biol. Chem. 278:6307-6313(2003).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14688616; DOI=10.1097/01.wcb.0000095920.70924.f5;
RA   Matsumoto S., Shamloo M., Matsumoto E., Isshiki A., Wieloch T.;
RT   "Protein kinase C-gamma and calcium/calmodulin-dependent protein kinase II-
RT   alpha are persistently translocated to cell membranes of the rat brain
RT   during and after middle cerebral artery occlusion.";
RL   J. Cereb. Blood Flow Metab. 24:54-61(2004).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF GRIN1/NMDAR1.
RX   PubMed=15936117; DOI=10.1016/j.neuint.2005.04.011;
RA   Sanchez-Perez A.M., Felipo V.;
RT   "Serines 890 and 896 of the NMDA receptor subunit NR1 are differentially
RT   phosphorylated by protein kinase C isoforms.";
RL   Neurochem. Int. 47:84-91(2005).
RN   [10]
RP   FUNCTION IN CELL SURVIVAL.
RX   PubMed=15705736; DOI=10.1124/jpet.104.082735;
RA   Hamabe W., Fujita R., Ueda H.;
RT   "Insulin receptor-protein kinase C-gamma signaling mediates inhibition of
RT   hypoxia-induced necrosis of cortical neurons.";
RL   J. Pharmacol. Exp. Ther. 313:1027-1034(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; SER-328; SER-330;
RP   THR-655 AND SER-687, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   STRUCTURE BY NMR OF 91-172 IN COMPLEX WITH PHORBOL-12,13-DIBUTYRATE, AND
RP   FUNCTION.
RX   PubMed=9271501; DOI=10.1021/bi970833a;
RA   Xu R.X., Pawelczyk T., Xia T.-H., Brown S.C.;
RT   "NMR structure of a protein kinase C-gamma phorbol-binding domain and study
RT   of protein-lipid micelle interactions.";
RL   Biochemistry 36:10709-10717(1997).
CC   -!- FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-
CC       dependent serine/threonine-protein kinase that plays diverse roles in
CC       neuronal cells and eye tissues, such as regulation of the neuronal
CC       receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and
CC       neuronal functions related to sensitivity to opiates, pain and alcohol,
CC       mediation of synaptic function and cell survival after ischemia, and
CC       inhibition of gap junction activity after oxidative stress. Binds and
CC       phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its
CC       function by increasing plasma membrane-associated GRIA4 expression. In
CC       primary cerebellar neurons treated with the agonist 3,5-
CC       dihyidroxyphenylglycine, functions downstream of the metabotropic
CC       glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor
CC       which plays a key role in synaptic plasticity, synaptogenesis,
CC       excitotoxicity, memory acquisition and learning. May be involved in the
CC       regulation of hippocampal long-term potentiation (LTP), but may be not
CC       necessary for the process of synaptic plasticity. May be involved in
CC       desensitization of mu-type opioid receptor-mediated G-protein
CC       activation in the spinal cord, and may be critical for the development
CC       and/or maintenance of morphine-induced reinforcing effects in the
CC       limbic forebrain. May modulate the functionality of mu-type-opioid
CC       receptors by participating in a signaling pathway which leads to the
CC       phosphorylation and degradation of opioid receptors. May also
CC       contributes to chronic morphine-induced changes in nociceptive
CC       processing. Plays a role in neuropathic pain mechanisms and contributes
CC       to the maintenance of the allodynia pain produced by peripheral
CC       inflammation. Plays an important role in initial sensitivity and
CC       tolerance to ethanol, by mediating the behavioral effects of ethanol as
CC       well as the effects of this drug on the GABA(A) receptors. During and
CC       after cerebral ischemia modulate neurotransmission and cell survival in
CC       synaptic membranes, and is involved in insulin-induced inhibition of
CC       necrosis, an important mechanism for minimizing ischemic injury.
CC       Required for the elimination of multiple climbing fibers during
CC       innervation of Purkinje cells in developing cerebellum. Is activated in
CC       lens epithelial cells upon hydrogen peroxide treatment, and
CC       phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of
CC       GJA1 gap junction plaques and inhibition of gap junction activity which
CC       could provide a protective effect against oxidative stress.
CC       Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in
CC       response to DNA damage. Involved in the phase resetting of the cerebral
CC       cortex circadian clock during temporally restricted feeding. Stabilizes
CC       the core clock component BMAL1 by interfering with its ubiquitination,
CC       thus suppressing its degradation, resulting in phase resetting of the
CC       cerebral cortex clock (By similarity). Phosphorylates and activates
CC       LRRK1, which phosphorylates RAB proteins involved in intracellular
CC       trafficking (By similarity). {ECO:0000250|UniProtKB:P05129,
CC       ECO:0000250|UniProtKB:P63318, ECO:0000269|PubMed:10336135,
CC       ECO:0000269|PubMed:12471040, ECO:0000269|PubMed:15705736,
CC       ECO:0000269|PubMed:15936117, ECO:0000269|PubMed:9271501,
CC       ECO:0000269|PubMed:9287082}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC         Evidence={ECO:0000250|UniProtKB:P05129};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13; Evidence={ECO:0000250|UniProtKB:P05129};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00041};
CC       Note=Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2
CC       domain. {ECO:0000250|UniProtKB:P05129};
CC   -!- ACTIVITY REGULATION: Classical (or conventional) PKCs (PRKCA, PRKCB and
CC       PRKCG) are activated by calcium and diacylglycerol (DAG) in the
CC       presence of phosphatidylserine. Three specific sites; Thr-514
CC       (activation loop of the kinase domain), Thr-655 (turn motif) and Thr-
CC       674 (hydrophobic region), need to be phosphorylated for its full
CC       activation.
CC   -!- SUBUNIT: Interacts with GRIA4. Interacts with CDCP1, TP53INP1 and
CC       p53/TP53 (By similarity). Interacts with BMAL1 (By similarity).
CC       {ECO:0000250|UniProtKB:P05129, ECO:0000250|UniProtKB:P63318,
CC       ECO:0000269|PubMed:12471040}.
CC   -!- INTERACTION:
CC       P63319; P53667: LIMK1; Xeno; NbExp=3; IntAct=EBI-12598030, EBI-444403;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P63318}.
CC       Cytoplasm, perinuclear region. Cell membrane
CC       {ECO:0000269|PubMed:12471040, ECO:0000269|PubMed:14688616}; Peripheral
CC       membrane protein. Synapse, synaptosome {ECO:0000269|PubMed:14688616}.
CC       Cell projection, dendrite {ECO:0000269|PubMed:10336135}.
CC       Note=Translocates to synaptic membranes on stimulation.
CC       {ECO:0000269|PubMed:14688616}.
CC   -!- PTM: Autophosphorylation on Thr-674 appears to regulate motor functions
CC       of junctophilins, JPH3 and JPH4. {ECO:0000250|UniProtKB:P63318}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:P05129}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X07287; CAA30267.1; -; mRNA.
DR   EMBL; M13707; AAA41874.1; -; mRNA.
DR   EMBL; BC089226; AAH89226.1; -; mRNA.
DR   EMBL; M55417; AAA41873.1; -; Genomic_DNA.
DR   PIR; A05105; KIRTGC.
DR   RefSeq; NP_036760.1; NM_012628.1.
DR   PDB; 1TBN; NMR; -; A=91-172.
DR   PDB; 1TBO; NMR; -; A=91-172.
DR   PDBsum; 1TBN; -.
DR   PDBsum; 1TBO; -.
DR   AlphaFoldDB; P63319; -.
DR   SMR; P63319; -.
DR   BioGRID; 246813; 24.
DR   IntAct; P63319; 2.
DR   MINT; P63319; -.
DR   STRING; 10116.ENSRNOP00000071203; -.
DR   BindingDB; P63319; -.
DR   ChEMBL; CHEMBL3604; -.
DR   DrugCentral; P63319; -.
DR   GlyGen; P63319; 10 sites, 1 O-linked glycan (10 sites).
DR   iPTMnet; P63319; -.
DR   PhosphoSitePlus; P63319; -.
DR   PaxDb; 10116-ENSRNOP00000019825; -.
DR   Ensembl; ENSRNOT00000080032.2; ENSRNOP00000071203.1; ENSRNOG00000054371.2.
DR   Ensembl; ENSRNOT00055050273; ENSRNOP00055041368; ENSRNOG00055029017.
DR   Ensembl; ENSRNOT00060043546; ENSRNOP00060036092; ENSRNOG00060025148.
DR   Ensembl; ENSRNOT00065053043; ENSRNOP00065043570; ENSRNOG00065030766.
DR   GeneID; 24681; -.
DR   KEGG; rno:24681; -.
DR   UCSC; RGD:3397; rat.
DR   AGR; RGD:3397; -.
DR   CTD; 5582; -.
DR   RGD; 3397; Prkcg.
DR   eggNOG; KOG0696; Eukaryota.
DR   GeneTree; ENSGT00940000161219; -.
DR   HOGENOM; CLU_000288_54_2_1; -.
DR   InParanoid; P63319; -.
DR   OMA; DADNCGL; -.
DR   OrthoDB; 841660at2759; -.
DR   PhylomeDB; P63319; -.
DR   TreeFam; TF351133; -.
DR   Reactome; R-RNO-111933; Calmodulin induced events.
DR   Reactome; R-RNO-114516; Disinhibition of SNARE formation.
DR   Reactome; R-RNO-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-RNO-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-RNO-76005; Response to elevated platelet cytosolic Ca2+.
DR   EvolutionaryTrace; P63319; -.
DR   PRO; PR:P63319; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000054371; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0044305; C:calyx of Held; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0099523; C:presynaptic cytosol; ISO:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004698; F:calcium,diacylglycerol-dependent serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0004697; F:diacylglycerol-dependent serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0007635; P:chemosensory behavior; ISO:RGD.
DR   GO; GO:0060384; P:innervation; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0007611; P:learning or memory; IEP:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IDA:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0016310; P:phosphorylation; IEA:Ensembl.
DR   GO; GO:0032425; P:positive regulation of mismatch repair; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0050764; P:regulation of phagocytosis; ISO:RGD.
DR   GO; GO:0032095; P:regulation of response to food; ISS:UniProtKB.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; ISO:RGD.
DR   GO; GO:0043278; P:response to morphine; ISS:UniProtKB.
DR   GO; GO:0048265; P:response to pain; ISS:UniProtKB.
DR   GO; GO:1990911; P:response to psychosocial stress; IDA:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   CDD; cd20833; C1_cPKC_rpt1; 1.
DR   CDD; cd20836; C1_cPKC_rpt2; 1.
DR   CDD; cd04026; C2_PKC_alpha_gamma; 1.
DR   CDD; cd05587; STKc_cPKC; 1.
DR   Gene3D; 3.30.60.20; -; 2.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014375; Protein_kinase_C_a/b/g.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22968:SF27; PROTEIN KINASE C; 1.
DR   PANTHER; PTHR22968; PROTEIN KINASE C, MU; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000550; PKC_alpha; 1.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Biological rhythms; Calcium; Cell membrane;
KW   Cell projection; Cytoplasm; Kinase; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Synapse; Synaptosome; Transferase;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..697
FT                   /note="Protein kinase C gamma type"
FT                   /id="PRO_0000055692"
FT   DOMAIN          157..275
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          351..614
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          615..685
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   ZN_FING         35..85
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         100..150
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ACT_SITE        480
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         186
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P63318"
FT   BINDING         187
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         187
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         193
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         246
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         246
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         247
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         248
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         248
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         248
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         251
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         252
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         254
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         254
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P05129"
FT   BINDING         357..365
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         380
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         250
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P63318"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P63318"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         328
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         332
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P63318"
FT   MOD_RES         373
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P63318"
FT   MOD_RES         514
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000250|UniProtKB:P63318"
FT   MOD_RES         648
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         655
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         674
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P63318"
FT   MOD_RES         675
FT                   /note="Phosphotyrosine; by SYK"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:1TBN"
FT   STRAND          108..110
FT                   /evidence="ECO:0007829|PDB:1TBN"
FT   STRAND          115..117
FT                   /evidence="ECO:0007829|PDB:1TBN"
FT   STRAND          125..127
FT                   /evidence="ECO:0007829|PDB:1TBN"
FT   STRAND          129..131
FT                   /evidence="ECO:0007829|PDB:1TBN"
FT   TURN            132..134
FT                   /evidence="ECO:0007829|PDB:1TBN"
FT   TURN            140..145
FT                   /evidence="ECO:0007829|PDB:1TBN"
SQ   SEQUENCE   697 AA;  78358 MW;  E6E2F7A3B93042FF CRC64;
     MAGLGPGGGD SEGGPRPLFC RKGALRQKVV HEVKSHKFTA RFFKQPTFCS HCTDFIWGIG
     KQGLQCQVCS FVVHRRCHEF VTFECPGAGK GPQTDDPRNK HKFRLHSYSS PTFCDHCGSL
     LYGLVHQGMK CSCCEMNVHR RCVRSVPSLC GVDHTERRGR LQLEIRAPTS DEIHITVGEA
     RNLIPMDPNG LSDPYVKLKL IPDPRNLTKQ KTKTVKATLN PVWNETFVFN LKPGDVERRL
     SVEVWDWDRT SRNDFMGAMS FGVSELLKAP VDGWYKLLNQ EEGEYYNVPV ADADNCSLLQ
     KFEACNYPLE LYERVRMGPS SSPIPSPSPS PTDSKRCFFG ASPGRLHISD FSFLMVLGKG
     SFGKVMLAER RGSDELYAIK ILKKDVIVQD DDVDCTLVEK RVLALGGRGP GGRPHFLTQL
     HSTFQTPDRL YFVMEYVTGG DLMYHIQQLG KFKEPHAAFY AAEIAIGLFF LHNQGIIYRD
     LKLDNVMLDA EGHIKITDFG MCKENVFPGS TTRTFCGTPD YIAPEIIAYQ PYGKSVDWWS
     FGVLLYEMLA GQPPFDGEDE EELFQAIMEQ TVTYPKSLSR EAVAICKGFL TKHPGKRLGS
     GPDGEPTIRA HGFFRWIDWE RLERLEIAPP FRPRPCGRSG ENFDKFFTRA APALTPPDRL
     VLASIDQADF QGFTYVNPDF VHPDARSPTS PVPVPVM
//
